Mitsubishi Beats Bid To Invalidate Diabetes Drug Patents
A New Jersey federal judge has refused to invalidate patents for Mitsubishi Tanabe Pharma Corp.'s diabetes drugs Invokana and Invokamet, striking down Zydus Pharmaceuticals Ltd.'s bid to dodge patent infringement claims...To view the full article, register now.
Already a subscriber? Click here to view full article